LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M

    Mao, Long / Shaabani, Namir / Zhang, Xiaoying / Jin, Can / Xu, Wanhong / Argent, Christopher / Kushnareva, Yulia / Powers, Colin / Stegman, Karen / Liu, Jia / Xie, Hui / Xu, Changxu / Bao, Yimei / Xu, Lijun / Zhang, Yuren / Yang, Haigang / Qian, Shengdian / Hu, Yong / Shao, Jianping /
    Zhang, Can / Li, Tingting / Li, Yi / Liu, Na / Lin, Zhenhao / Wang, Shanbo / Wang, Chao / Shen, Wei / Lin, Yuanlong / Shu, Dan / Zhu, Zhenhong / Kotoi, Olivia / Kerwin, Lisa / Han, Qing / Chumakova, Ludmila / Teijaro, John / Royal, Mike / Brunswick, Mark / Allen, Robert / Ji, Henry / Lu, Hongzhou / Xu, Xiao

    Med (New York, N.Y.)

    2024  Volume 5, Issue 1, Page(s) 42–61.e23

    Abstract: Background: Oral antiviral drugs with improved antiviral potency and safety are needed to address current challenges in clinical practice for treatment of COVID-19, including the risks of rebound, drug-drug interactions, and emerging resistance.: ... ...

    Abstract Background: Oral antiviral drugs with improved antiviral potency and safety are needed to address current challenges in clinical practice for treatment of COVID-19, including the risks of rebound, drug-drug interactions, and emerging resistance.
    Methods: Olgotrelvir (STI-1558) is designed as a next-generation antiviral targeting the SARS-CoV-2 main protease (M
    Findings: Olgotrelvir is a highly bioavailable oral prodrug that is converted in plasma to its active form, AC1115. The dual mechanism of action of olgotrelvir and AC1115 was confirmed by enzyme activity inhibition assays and co-crystal structures of AC1115 with SARS-CoV-2 M
    Conclusions: Olgotrelvir is an oral inhibitor targeting M
    Funding: Funded by Sorrento Therapeutics.
    MeSH term(s) Animals ; Humans ; Mice ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Cathepsin L/antagonists & inhibitors ; COVID-19/prevention & control ; Disease Models, Animal ; Mice, Transgenic ; SARS-CoV-2 ; Coronavirus Protease Inhibitors/chemistry ; Coronavirus Protease Inhibitors/pharmacology ; Coronavirus 3C Proteases/antagonists & inhibitors ; COVID-19 Drug Treatment/methods
    Chemical Substances Antiviral Agents ; Cathepsin L (EC 3.4.22.15) ; STI-1558 ; Coronavirus Protease Inhibitors ; Coronavirus 3C Proteases (EC 3.4.22.28)
    Language English
    Publishing date 2024-01-04
    Publishing country United States
    Document type Journal Article
    ISSN 2666-6340
    ISSN (online) 2666-6340
    DOI 10.1016/j.medj.2023.12.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M

    Mao, Long / Shaabani, Namir / Zhang, Xiaoying / Jin, Can / Xu, Wanhong / Argent, Christopher / Kushnareva, Yulia / Powers, Colin / Stegman, Karen / Liu, Jia / Xie, Hui / Xu, Changxu / Bao, Yimei / Xu, Lijun / Zhang, Yuren / Yang, Haigang / Qian, Shengdian / Hu, Yong / Shao, Jianping /
    Zhang, Can / Li, Tingting / Li, Yi / Liu, Na / Lin, Zhenhao / Wang, Shanbo / Wang, Chao / Shen, Wei / Lin, Yuanlong / Shu, Dan / Zhu, Zhenhong / Kotoi, Olivia / Kerwin, Lisa / Han, Qing / Chumakova, Ludmila / Teijaro, John / Royal, Mike / Brunswick, Mark / Allen, Robert / Ji, Henry / Lu, Hongzhou / Xu, Xiao

    Med (New York, N.Y.)

    2024  Volume 5, Issue 2, Page(s) 169–171

    Language English
    Publishing date 2024-02-02
    Publishing country United States
    Document type Published Erratum
    ISSN 2666-6340
    ISSN (online) 2666-6340
    DOI 10.1016/j.medj.2024.01.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top